ChristopherTan (Chris)

Associate

Sydney + 61.2.8272.0518

Chris Tan's practice focuses on M&A, corporate governance, and general corporate and commercial law. He has advised domestic and international clients on a broad range of commercial and corporate matters including business acquisitions and disposals, joint ventures, corporate restructurings, foreign investment laws, and general corporate governance matters.

Chris has advised clients across a broad range of sectors, including energy and resources, financial services, IT, and the manufacturing, distribution, and retail industries. He also regularly advises companies and directors on their corporate governance and compliance obligations under the Corporations Act.

Experience

  • OMERS completes US$490 million acquisition of shares in ESR Cayman LimitedJones Day advised OMERS Administration Corporation, the pension plan for Ontario's municipal employees, in connection with its US$490 million acquisition of Equity Shares in Hong Kong listed ESR Cayman Limited ("ESR"), a leading pan-Asia logistics real estate platform, from an affiliate of Warburg Pincus.
  • Cleveland-Cliffs completes offers to exchange 6.375% Senior Notes and 7.00% Senior Notes issued by AK Steel CorporationJones Day represented Cleveland-Cliffs Inc. (“Cliffs”), a large vertically integrated producer of differentiated iron ore and steel in North America, in connection with its offers to exchange any and all 6.375% Senior Notes due 2025 and 7.00% Senior Notes due 2027 issued by AK Steel Corporation for the same aggregate principal amount of new notes issued by Cliffs’.
  • Cleveland-Cliffs issues $725 million of 6.75% Senior Secured NotesJones Day represented Cleveland-Cliffs Inc. ("Cliffs"), a large vertically integrated producer of differentiated iron ore and steel in North America, in connection with an offering of $725 million aggregate principal amount of 6.75% Senior Secured Notes due 2026.
  • True Capital invests £26 million in Soulfresh GroupJones Day represented True Capital Limited in connection with their £26 million investment in the Soulfresh Group, a food and beverage group headquartered in Melbourne, Australia providing a range of produce with a health and sustainability focus including fermented beverages and plant-based food and drinks.
  • Horizon Global sells Asia-Pacific Business segment to Pacific Equity Partners for AU$340 million (US$233 million)Jones Day advised Horizon Global Corporation (NYSE: HZN), one of the world's leading manufacturers of branded towing, trailering, cargo management, and related accessories, on the AU$340 million (US$233 million) sale of its Australian and Asia-Pacific division to Pacific Equity Partners.
  • Kaplan acquires Red MarkerJones Day advised Kaplan Inc. on its acquisition, acting through Kaplan Australia Pty Ltd, of all of the issued share capital of Red Marker Pty Ltd together with all vested and unvested options for shares issued by the company.
  • Bloomfield Collieries acquires open cut coal mine assets from Glencore Coal and Integra coal joint venturersJones Day represented Bloomfield Collieries Pty Ltd. in the acquisition of the Integra open cut coal mine assets from Glencore Coal and the Integra coal joint venturers, including Vale.
  • XIO acquires Lumenis for approximately $510 million, $14 per share, in cashJones Day advised XIO Group in its acquisition of Lumenis Ltd., the world's largest energy-based medical company for surgical, ophthalmology, and aesthetic applications, for $14 per share in cash, for an aggregate purchase price of approximately $510 million.
  • Stallergenes merges with Greer Laboratories and forms global leader in allergy immunotherapyJones Day advised Stallergenes, a French Euronext-listed company, in a merger with its U.S. partner Greer Laboratories, to create Ares Allergy Holdings plc, a global leader in allergy immunotherapy listed on Euronext Paris with a market capitalization of approximately €958 million (US$1.07 billion).
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.